WALL, N.J., May 31, 2011 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (OTCBB:BKYI), a global leader in finger biometric identification technology solutions, today announced that Nationwide Children's Hospital, one of the largest and most comprehensive pediatric hospitals and research institutes in the United States, has implemented BIO-key's Positive ID Director for Epic, into their Epic user's workflow to insure their compliance with the Ohio Board of Pharmacies Positive ID requirements.
"Nationwide Children's Hospital has been using biometrics in association with our electronic medical records for over ten years. Our old biometrics solution never met our requirements. Upon witnessing significant improvements in the hospitals ability to enroll users, provide an accurate and consistent authentication experience and offer a convenient flexible transition, the hospital elected to migrate to the BIO-key Positive ID system" stated Michael Hunt Information Services – Technology and Infrastructure Coordinator, Nationwide Children's Hospital.
Nationwide Children's Hospital is a resource and an advocate for children and parents in central Ohio and far beyond. In a typical year they will see patients from across the United States and around the world.
"Incorporating biometric technology is consistent with Nationwide Children's Hospital core values; one of which includes "innovation". Upgrading the system with BIO-key's software will enable Nationwide to offer a safer and more secure healthcare environment and validates Nationwide's commitment to optimum security for patients and staff" stated Ben Hammel Director of Identity Management Solutions, BIO-key International. We believe that in the very near future every hospital will be incorporating biometric technology as a gateway to EMR & EHR along with other hospital applications which require strong security" added Hammel.
BIO-key's Positive ID Director, is powered by BIO-key's award winning software. In addition to Nationwide Children's Hospital, BIO-key software is utilized by leading hospitals, blood banks, EMR & EHR providers and healthcare facilities throughout the United States and by commercial enterprise and government agencies across the globe.
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. ()
BIO-key Safe Harbor Statement
Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, and our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2009 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
CONTACT: BIO-key International, Inc. Scott Mahnken 732-359-1113